Search
Baxter International Inc
BAXAdd to Watchlist
20.965USD
+0.865+4.30%
Market hours （ET）Quotes delayed by 15 min
10.83BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+4.30%
5 Days
+2.47%
1 Month
+9.31%
6 Months
+10.75%
Year to Date
+9.71%
1 Year
-30.09%
Key Figures
20.370Open
20.970High
2.04MVolume
LossP/E TTM
10.60P/E Dynamic
0.360Dividend TTM
0.39%Turnover Ratio
20.100Prev. Close
20.310Low
24.65MTurnover
LossP/E Static
1.79P/B
1.72%Div Yield TTM
-4.77%ROA
32.04052wk High
0.58Volume Ratio
-649.00MNet Profit
516.45MShares
-2.1407EPS TTM
0.65Beta
-14.95%ROE
15.73052wk Low
3.28%Amplitude
33.40%Gross Margin
10.83BMarket Cap
2.31Reward/Risk
2.08%Risk Rate
TradingKey Stock Score of Baxter International Inc
Currency: USD Updated: 2026-06-23Key Insights
Baxter International Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 77 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 21.05.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Baxter International Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Baxter International Inc Highlights
StrengthsRisks
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Fairly Valued
The company’s latest PE is -9.39, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 557.84M shares, decreasing 7.52% quarter-over-quarter.
Held by Richard Pzena
Star Investor Richard Pzena holds 55.87M shares of this stock.
Analyst Rating
Based on
17
analysts
Hold
Current Rating
21.051
Target Price
+7.07%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Baxter International Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Baxter International Inc Info
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Ticker SymbolBAX
CompanyBaxter International Inc
CEOHider (Andrew P)
Websitehttps://www.baxter.com/
Related Instruments
-0.87%
+4.11%
+0.39%
+0.04%
+5.10%
-0.50%
+2.01%
+0.07%
+0.84%
-2.20%
-1.31%
-1.41%
+2.13%
+3.17%
+2.22%
-0.48%
+2.55%
+4.03%
+10.18%
+4.29%Popular Instruments
70.659
-2.286 (-3.13%)
298.355
+4.055 (+1.38%)
200.900
+0.860 (+0.43%)
4017.850
-92.900 (-2.26%)
643.710
-27.040 (-4.03%)
1928.055
-35.545 (-1.81%)
1046.670
-5.100 (-0.48%)
350.179
+4.049 (+1.17%)
60269.730
-2170.970 (-3.48%)
381.660
+0.050 (+0.01%)
FAQs
What is the current price of Baxter International Inc (BAX)?
The current price of Baxter International Inc (BAX) is 20.10.
What is the symbol of Baxter International Inc?
The ticker symbol of Baxter International Inc is BAX.
What is the 52-week high of Baxter International Inc?
The 52-week high of Baxter International Inc is 32.04.
What is the 52-week low of Baxter International Inc?
The 52-week low of Baxter International Inc is 15.73.
What is the market capitalization of Baxter International Inc?
The market capitalization of Baxter International Inc is 10.38B.
Is Baxter International Inc (BAX) currently rated as Buy, Hold, or Sell?
According to analysts, Baxter International Inc (BAX) has an overall rating of signal_hold, with a price target of 21.05.
What is the Earnings Per Share (EPS TTM) of Baxter International Inc (BAX)?
The Earnings Per Share (EPS TTM) of Baxter International Inc (BAX) is -1.87.
